Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Colesevelam hydrochloride | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the additional lowering of HbA1c achieved by addition of colesevelam hydrochloride to current antidiabetic therapy |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the fasting plasma glucose and fructosamine lowering efficacy; | ||
| To assess glycemic control response rate; | ||
| To assess the improvement in insulin sensitivity; |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Birmingham | Alabama | United States | ||||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 18458145 | Derived | Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care. 2008 Aug;31(8):1479-84. doi: 10.2337/dc08-0283. Epub 2008 May 5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| To assess the effect on C reactive protein; |
| To assess lipids and lipoproteins; |
| To assess the safety and tolerability of colesevelam hydrochloride as add-on therapy |
| Tuscumbia |
| Alabama |
| United States |
| Little Rock | Arkansas | United States |
| Searcy | Arkansas | United States |
| Concord | California | United States |
| Irvine | California | United States |
| La Jolla | California | United States |
| Los Angeles | California | United States |
| Los Gatos | California | United States |
| West Hills | California | United States |
| Coral Gables | Florida | United States |
| Miami | Florida | United States |
| New Port Richey | Florida | United States |
| Pembroke Pines | Florida | United States |
| West Palm Beach | Florida | United States |
| Atlanta | Georgia | United States |
| Chicago | Illinois | United States |
| Indianapolis | Indiana | United States |
| New Orleans | Louisiana | United States |
| Boston | Massachusetts | United States |
| Kansas City | Missouri | United States |
| St Louis | Missouri | United States |
| Rochester | New York | United States |
| Charlotte | North Carolina | United States |
| Hickory | North Carolina | United States |
| Statesville | North Carolina | United States |
| Winston-Salem | North Carolina | United States |
| Cincinnati | Ohio | United States |
| Cleveland | Ohio | United States |
| Marion | Ohio | United States |
| Perrysburg | Ohio | United States |
| Oklahoma City | Oklahoma | United States |
| Tulsa | Oklahoma | United States |
| Portland | Oregon | United States |
| Beaver | Pennsylvania | United States |
| Charleston | South Carolina | United States |
| Bristol | Tennessee | United States |
| Dallas | Texas | United States |
| Houston | Texas | United States |
| Midland | Texas | United States |
| San Antonio | Texas | United States |
| Arlington | Virginia | United States |
| Richmond | Virginia | United States |
| Lakewood | Washington | United States |
| Renton | Washington | United States |
| Mexico City | Mexico |
| Lima | Peru |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069472 | Colesevelam Hydrochloride |
| ID | Term |
|---|---|
| D000499 | Allylamine |
| D000588 | Amines |
| D009930 | Organic Chemicals |
| D000498 | Allyl Compounds |
| D000475 | Alkenes |
| D006839 | Hydrocarbons, Acyclic |
| D006838 | Hydrocarbons |
Not provided
Not provided